Literature DB >> 7867199

Effect of beta-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise.

J H Traverse1, J D Altman, J Kinn, D J Duncker, R J Bache.   

Abstract

BACKGROUND: beta-Adrenergic receptors have been identified in isolated coronary collateral blood vessels, but their functional significance in the intact heart has not been demonstrated. METHODS AND
RESULTS: We measured myocardial blood flow with radioactive microspheres in normal and collateral-dependent myocardium in eight dogs trained to run on a treadmill before and after beta-adrenergic blockade with propranolol, 200 micrograms/kg, a dose that effectively inhibited the increase in coronary blood flow produced by selective beta 1- and beta 2-adrenergic agonists. Collateral vessel growth was stimulated with 2-minute intermittent occlusions of the left anterior descending artery followed by permanent occlusion. During control exercise, blood flow in the collateral zone was 38 +/- 5% less than in the normal zone. At identical levels of exercise, with heart rate maintained constant by atrial pacing, propranolol decreased mean blood flow in the collateralized myocardium from 1.93 +/- 0.17 to 1.50 +/- 0.14 mL.min-1.g-1 (P < .01), while increasing the subendocardial to subepicardial blood flow ratio from 0.78 +/- 0.11 to 0.91 +/- 0.10 (P < .05). The decrease in collateral zone blood flow in response to propranolol resulted from an increase in both transcollateral resistance from 25.9 +/- 2.3 to 35.2 +/- 4.3 mm Hg.mL-1.min.g (P < .05) and small-vessel resistance in the collateral-dependent myocardium from 30.9 +/- 4.7 to 44.0 +/- 8.8 mm Hg.mL-1.min.g (P < .07). Blood flow to the normal zone was also significantly reduced from 3.14 +/- 0.21 to 2.23 +/- 0.12 mL.min-1.g-1 (P < .01) after propranolol.
CONCLUSIONS: beta-Adrenergic blockade decreased blood flow to collateral-dependent myocardium during exercise. These results indicate that beta-adrenergic receptor activation contributes to vasodilation of coronary collateral vessels during exercise.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7867199     DOI: 10.1161/01.cir.91.5.1560

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Comparison of nifedipine and metoprolol on collateral coronary blood flow in a swine model of chronic coronary obstruction and acute ischaemia during isoflurane anaesthesia.

Authors:  D C Cheng; M T Jiang; B Asokumar; P Boylen; A Sandler
Journal:  Can J Anaesth       Date:  1996-02       Impact factor: 5.063

2.  Beta-1 vs. beta-2 adrenergic control of coronary blood flow during isometric handgrip exercise in humans.

Authors:  Stephan R Maman; Alvaro F Vargas; Tariq Ali Ahmad; Amanda J Miller; Zhaohui Gao; Urs A Leuenberger; David N Proctor; Matthew D Muller
Journal:  J Appl Physiol (1985)       Date:  2017-06-01

3.  Cardiovascular drugs attenuated myocardial resistance against ischaemia-induced and reperfusion-induced injury in a rat model of repetitive occlusion.

Authors:  Nora Gatzke; Nadija Güc; Philipp Hillmeister; André Dülsner; Ferdinand Le Noble; Eva Elina Buschmann; Maja Ingwersen; Peter Bramlage; Ivo R Buschmann
Journal:  Open Heart       Date:  2018-12-04

4.  Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the β adrenergic system.

Authors:  Gaetano Santulli; Michele Ciccarelli; Bruno Trimarco; Guido Iaccarino
Journal:  Front Physiol       Date:  2013-08-12       Impact factor: 4.566

Review 5.  Pathophysiology of coronary collaterals.

Authors:  Michael Stoller; Christian Seiler
Journal:  Curr Cardiol Rev       Date:  2014-02

6.  Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy.

Authors:  Christopher L Moore; David S Henry; Samantha J McClenahan; Kelly K Ball; Nancy J Rusch; Sung W Rhee
Journal:  J Pharmacol Exp Ther       Date:  2020-10-25       Impact factor: 4.030

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.